Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bavarian Nordic
Biotech
Bavarian Nordic halts cancer vaccine program
Bavarian Nordic may be celebrating its most profitable year yet, but that hasn’t stopped the Danish biotech from streamlining its portfolio.
James Waldron
Feb 21, 2024 7:25am
BioNTech pockets $90M from CEPI to partner on mpox vaccine
Sep 18, 2023 10:30am
Variant vulnerability vanquishes Bavarian Nordic's COVID vaccine
Sep 1, 2023 5:39am
Bavarian Nordic goes 2 for 2 in key chikungunya vaccine trials
Aug 7, 2023 5:40am
Bavarian Nordic crashes out of RSV race after phase 3 trial
Jul 24, 2023 5:00am
Bavarian Nordic chikungunya vaccine hits primary goal in phase 3
Jun 20, 2023 9:00am